small molecule glp 1 agonist Binding sites and design strategies for GLP-1R agonists Orforglipron FDA Approval: Why the

In a clinical trial involving 112 patients, administration of the GLP-1 analogue exenatide led to a 21% faster reduction in blood lactate levels within 6 hours compared to placebo (95% CI: 6.0%33%

The introduction of oral GLP-1 receptor agonists has offered patients a convenient way to effectively manage their weight and adhere to the medication regimen

A robust pipeline of oral GLP-1 agents and next-generation therapies with complementary mechanisms is advancing swiftly, intensifying competition and expanding future treatment possibilities

The plaintiff must demonstrate, through expert testimony supported by clinical evidence, that the medication more likely than not caused the injury

Bupropion is a norepinephrine-dopamine reuptake inhibitor that increases alertness and reduces appetite by elevating dopamine and norepinephrine in the brain's appetite-control centers